Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 29 | 28 | 29 | 27 | 58 |
| Income taxes - deferred | 96 | 201 | 201 | 827 | -54 |
| Accounts receivable | -187 | -904 | -8 | -213 | -528 |
| Accounts payable and accrued liabilities | -702 | -98 | -490 | 1,225 | 419 |
| Other Working Capital | -2,024 | -3,386 | -1,990 | 4,826 | -316 |
| Other Operating Activity | 1,813 | 3,324 | 1,369 | -6,480 | 1,012 |
| Operating Cash Flow | $-975 | $-833 | $-889 | $212 | $591 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | 0 | -70 |
| Net Acquisitions | -212 | 0 | -1,750 | N/A | 0 |
| Purchase Of Investment | -86,274 | -119,628 | -274,601 | -138,606 | -11,202 |
| Sale Of Investment | 2,023 | 170,202 | 279,731 | N/A | 0 |
| Other Investing Activity | 500 | -22,765 | 1,446 | 108,583 | -7,791 |
| Investing Cash Flow | $-83,963 | $27,809 | $4,827 | $-30,023 | $-19,063 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 0 | 2,500 |
| Debt Repayment | N/A | N/A | N/A | 0 | -2,500 |
| Common Stock Issued | 13 | 32 | 10 | N/A | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | -145 | -450 |
| Other Financing Activity | 0 | 934 | 12,853 | 83,172 | 246,145 |
| Financing Cash Flow | $13 | $965 | $12,862 | $83,027 | $245,695 |
| Exchange Rate Effect | 2,484 | -187 | 1,047 | N/A | 0 |
| Beginning Cash Position | 329,047 | 301,293 | 283,445 | 227,223 | 0 |
| End Cash Position | 246,606 | 329,047 | 301,293 | 283,445 | 227,223 |
| Net Cash Flow | $-84,925 | $27,941 | $16,800 | $53,216 | $227,223 |
| Free Cash Flow | |||||
| Operating Cash Flow | -975 | -833 | -889 | 212 | 591 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -70 |
| Free Cash Flow | -975 | -833 | -889 | 212 | 521 |